Recursion Pharmaceuticals Inc - Class A —— 财务报表 (NASDAQ:RXRX) | MetaTrader

展开完整图表

Recursion Pharmaceuticals Inc - Class A

Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering. The company is based in Salt Lake City, Utah. It was founded by Chris Gibson, Dean Li and Blake Borgeson.

新闻

Recursion Pharmaceuticals (RXRX) Stock Declines While Market Improves: Some Information for Investors

Recursion Pharmaceuticals (RXRX) Down 16.5% Since Last Earnings Report: Can It Rebound?

Bitcoin Skids, $14 Bil In Options Due; Cathie Wood Raises Cash

Recursion Pharmaceuticals, Inc. (RXRX) Presents at 2026 KeyBanc Capital Markets Healthcare Virtual Forum Transcript

Rose the dog might have just heralded the age of programmable medicine — and here are the stocks that benefit

Recursion Pharmaceuticals (RXRX) Sees a More Significant Dip Than Broader Market: Some Facts to Know

PacBio任命Recursion联合创始人Gibson加入董事会

Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down

Xenon Q4 Loss Wider Than Expected, Pipeline Development in Focus

Catalyst Pharmaceuticals Q4 Earnings Beat, Firdapse Revenues Rise Y/Y

ACAD Q4 Earnings Beat, Nuplazid & Daybue Drive Y/Y Revenue Growth

Recursion Pharmaceuticals, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:RXRX) 2026-02-25